16d06576ab837b8a489478d34ab01fd5.jpg

U.S. Army and University of Hawaii Forge Alliance to Advance Biomaterials and Defense Manufacturing

The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) and the University of Hawaii System recently formalized a collaborative initiative to enhance warfighter survivability and effectiveness. This partnership, strategically focused on leveraging biomaterials and advanced manufacturing capabilities, aims to strengthen defense efforts, particularly in support of the United States Indo-Pacific Command, which is headquartered in Hawaii.

bfcec32c875da8df9383b01461a22574.jpg

FDA Grants IND Approval to Triastek’s 3D Printed Oral Anticoagulant T20G

Triastek, a Chinese 3D printing pharmaceutical company, has announced that its proprietary 3D printed non-vitamin K antagonist oral anticoagulant (NOAC), T20G, has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) as of February 27, 2025. This regulatory achievement follows an earlier IND approval from China’s National Medical Products Administration (NMPA) in January 2024.

Axtra3D expands dental portfolio with new resins for its high-speed SLA printer

Axtra3D, a developer of high-speed stereolithography (SLA) systems, has introduced four new dental resins, expanding its portfolio of validated materials for the Lumia X1 printer. The new additions—NextDent Model Sand, Pro3dure Splint 19.1 AO/MSI, Pro3dure Denture 14.2, and Pro3dure Crown & Bridge—are now available with optimized print profiles, aimed at increasing accuracy and production efficiency for digitally manufactured dental models, splints, dentures, and restorations.